KalVista Pharmaceuticals, Inc. Stock Agreements
5 Contracts & Agreements
- KALVISTA PHARMACEUTICALS, INC. COMMON STOCK (par value$0.001 per share) AT-THE-MARKET SALES AGREEMENT (Filed With SEC on July 13, 2017)
- CARBYLAN THERAPEUTICS, INC. 2014 STOCK OPTION PLAN (Filed With SEC on December 29, 2014)
- CARBYLAN BIOSURGERY, INC. AMENDED AND RESTATED 2004 STOCK OPTION PLAN (as amended through December 19, 2012) (Filed With SEC on December 29, 2014)
- SECOND AMENDMENT TO WARRANT TO PURCHASE STOCK [October 26, 2011 Warrant] (Filed With SEC on December 29, 2014)
- FIRST AMENDMENT TO WARRANT TO PURCHASE STOCK [October 26, 2011 Warrant] (Filed With SEC on December 29, 2014)
